A Chinese Phase IIb trial of the mAb has already started, with Mabwell also hoping to initiate a Phase IIa trial in the US.

COPD, which includes chronic bronchitis and emphysema, is progressive, meaning it gets worse over time without treatment. People with COPD have difficulty breathing because of inflammation and damage ...

Remote interventions reduced hospital readmissions by over 50% in COPD patients, highlighting their potential to disrupt frequent exacerbation cycles. Significant improvements in quality of life were ...

India has the second-highest incidence of chronic obstructive pulmonary disease (CoPD) in the world, after China. What you need to know about CoPD and the cost of treatment for the chronic lung ...

Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...